As of 12:30 PM on the 30th, Jinwon Life Sciences is trading at 28,250 KRW, up 0.36% from the previous day. This is a 13.21% decrease compared to October 8. Jinwon Life Sciences is known as a company specializing in the development of gene therapies and gene vaccines.

Today, foreigners are tentatively recorded as net sellers of 31,000 shares. Over the past five days, individual investors have been net buyers of 160,055 shares, while foreigners and institutions have been net sellers of 192,171 shares and net buyers of 24,828 shares, respectively.


On October 29, Jinwon Life Sciences became a market issue with the headline "Strong performance following FDA clinical trial approval application for COVID-19 treatment."





[Table] Foreigners and Institutions Net Trading Volume (Unit: shares)

※ Source: AI Investment Assistant AI Rassiro


※ This article was generated in real-time by an automatic article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing